A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

NCT00138671 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

105

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetes Mellitus
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Subcutaneous Insulin
DRUG: Inhaled Insulin

Sponsor

Pfizer